Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • aberry814
    Junior Member
    • Jul 2015
    • 1

    #1

    Bowtie alignments and --local function

    I've just starting sequencing using MiSeq and am stumbling a bit in the analysis of my output reads, specifically using bowtie2 to align the reads to the reference genome. I'm using bowtie to get a rough estimate of what my amplification looks like and it's generally intuitive and quick. However:

    When aligning reads to a genome sequence, what is “% reads align exactly 1 time” vs “% reads align >1 times” in the output? From my understanding, bowtie only records the best possible match (by default).
    Is this saying that, to use an example from one of my samples, 40.26% of my reads align equally well to several places in the genome, suggesting a repeat region, while only 17.35% of my reads align to a unique region?
    Or should this be interpreted as 40% of the reads align somewhere in the genome that already has one or more reads assembled to it, and that 17% of my reads are “unique”?

    Also, my —-local alignments are substantially different (99% of reads align using —-local while only <70% without) from those where I do not specify —-local, even though I trim adapters and low quality reads before aligning (using trimmomatic). From my understanding of —-local, it should give a slightly more liberal alignment, but the two should be closer especially with trimming beforehand.

    Forgive my ignorance and thanks for any advice.

    Alex

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 10:13 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
29 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
21 views
0 reactions
Last Post SEQadmin2  
Working...